Skip to main content
Premium Trial:

Request an Annual Quote

Michael Cohen New CEO of MetriGenix; Heidi Bullock Leaves Vitra Biosciences; Naveen Kulkarni Goes to Polyclone from SysArris; Ren Bernards Wins Spinoza Prize, Claire Fraser Receives Promega Biotech Research Award; and Others

Michael Cohen has become the new chief scientific officer of Toronto-based MetriGenix, following the acquisition of GeneXP Biosciences by MetriGenix,. He is the former president of GeneXP.


 

Heidi Bullock has left her position as director of marketing for Vitra Biosciences, CBA News, a GenomeWeb newsletter, reported last week. No further details were given regarding her departure or replacement.


 

Naveen Kulkarni, who previously led the bioinformatics division at India's SysArris, has joined Polyclone Bioservices as chief executive officer, the company said last week. In addition, Praveen Rajendra has joined Polyclone as chief information officer. Rajendra previously worked at Nitya Technologies, a software services company based in Bangalore.


 

Frank Ryan has been elected as director of Digene by the company's board, the Gaithersburg, Md.-based company said last week. If his appointment is confirmed by the company's stockholders at their annual meeting this year, he will serve for a three-year term on Digene's board. Ryan used to be a group chairman of Johnson & Johnson until 2001. He holds an MBA from the Universityof Chicagoand graduated from the Illinois Institute of Technology.


 

Udo Henseler has joined the board of directors of Tutogen Medical, the West Paterson, NJ-based maker of tissue implants said yesterday. He is the chief executive officer and chairman of EGene. Henseler holds PhD and master's degrees from the Claremont Graduate University in Claremont, Calif., and an undergraduate degree from Germany.


 

René Bernards, chief scientific officer of Agendia, has won the Spinoza prize from the Dutch Organization for Scientific Research, Agendia said today. He also heads the division of molecular carcinogenesis at the Netherlands Cancer Institute.


 

Claire Fraser has won the 2005 Promega Biotechnology Research Award, the Institute for Genomic Research said this week. She is the president and director, as well as a co-founder, of Rockville, Md.-based TIGR. Fraser, who received the award on Monday at the general meeting of the American Society for Microbiology in Atlanta, is honored for her "outstanding contributions and research to the application of biotechnology through fundamental microbiological research and development." She holds a PhD in pharmacology from the State University of New York at Buffalo and a BS in biology from Rensselaer Polytechnic Institute in New York.


 

Alejandro Zaffaroni last month received the Gregory Pincus Award from the Worcester Foundation for Biological Research "for his visionary leadership in developing technologies and products ..., as well as his success in commercializing novel techniques for drug discovery and drug delivery."

 

The Uruguayan-born founder of Alza also co-founded Affymetrix, Perlegen Sciences, Dnax, Affymax, Symyx Technologies, Maxygen, SurroMed, and, most recently, Alexza MDC. Zaffaroni received holds a PhD in biochemistry from the Universityof Rochester and a BS from the Universityof Montevideo in Uruguay.

 

The Pincus award, established in 1969, is given annually by the Worcester Foundation at the University of Massachusetts Medical Center to recognize individuals who are pioneers in the fields of endocrine and reproductive biology.


 

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more